Is a  total dose of 54 Gy with radiochemotherapy sufficient for treatment of intermediate-risk volumes in nasopharyngeal cancer?

ConclusionThese retrospective data suggest that a  dose reduction may be possible for intermediate-risk volumes, especially for the primary site.
Source: Strahlentherapie und Onkologie - Category: Cancer & Oncology Source Type: research